Health Condition 1: M968- Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified
Conditions
Interventions
Intervention1: Levobupivacaine Bolus Dose: Intrathecal Levobupivacaine
0.5% heavy 3.5ml (17.5mg) along with an additive drug injection Buprenorphine 0.3ml(90mcg)
Control Intervention1: Levobupivacaine
Sponsors
Chettinad Hospital and Research Institute
Eligibility
Inclusion criteria
Inclusion criteria: 1) ASA GRADE 1, 2 & 3 patients 2) Elective and Emergency Surgeries under Spinal Anaesthesia
Exclusion criteria
Exclusion criteria: 1)Patients refusing to participate in the study 2)History of allergy to study drug 3)Patients with infection at the site of injection, coagulopathy, increased Intracranial Pressure 4)Severely altered mental status 5)Spine deformities or history of laminectomy 6)Unknown duration of surgery, 7)Patients converted to general anaesthesia intra-operatively.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare hemodynamic stability and to compare duration of analgesiaTimepoint: First 24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) To assess time of onset, level and regression of motor and sensory block 2) To assess two segment regression time 3) Requirement of vasopressors if anyTimepoint: First 24 hours | — |
Countries
India
Contacts
Public ContactJacinth Hazarika
Chettinad Hospital and Research Institute, Chennai
Outcome results
None listed